Tag: Emergency Use Authorizations

Non-Prescription COVID Tests

FDA Authorizes Non-Prescription COVID Tests

The FDA grants emergency use authorization for at-home, over-the-counter COVID-19 tests. On March 5, 2021, Cue Health received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for their Cue COVID-19 Test for Home and Over The Counter (OTC) Use. The nucleic acid amplification test (NAAT) detects the RNA of SARS-CoV-2, the […]
Learn More
COVID-19 Vaccination Reimbursement

Physicians Call for Fair Reimbursement for COVID-19 Vaccines

  Physicians are asking for adequate reimbursement for all COVID-19 vaccines and their administration, according to a new policy statement from the American College of Physicians (ACP). The statement released on Jan. 12 calls on health policymakers to require insurers to “provide adequate reimbursement for all vaccines, including COVID-19 vaccines, administered according to” scientific guidelines established by […]
Learn More
COVID-19 Billing

CMS Provides Updated Guidance on Billing For Covid-19 Monoclonal Antibody Treatments

  CMS updated its COVID-19 billing FAQs on October 28 to address billing scenarios for potential monoclonal antibody treatments. The two new FAQs, which appear in section BB. Drugs and Vaccines under Part B, address billing for monoclonal antibody treatments provided in the hospital outpatient setting. CMS notes that if a monoclonal antibody product is granted an […]
Learn More
x